Carl Icahn
Icahn Capital Management
Carl Icahn Enzon Pharmaceuticals Inc stake
total: 71
Icahn Capital Management ENZN trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2013 Q2 or earlier
- Held for:
- 12+ quarters
- Latest activity:
- 2016 Q2
According to 2026 Q2 report, Carl Icahn doesn't hold any Enzon Pharmaceuticals Inc (ENZN) shares. Icahn Capital Management has held ENZN since at least 2013 Q2 with about 5.90M shares in our earliest available record. Since at least 2013 Q2, Icahn Capital Management has made 1 more transaction.
When did Carl Icahn sell Enzon Pharmaceuticals Inc (ENZN)?
Carl Icahn sold off the entire Enzon Pharmaceuticals Inc (ENZN) position in 2016 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $2.00
- Weighted AVG sell price:
- $0.47
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.